You state that "avoidance of allogeneic transfusion has been adopted as the standard efficacy end-point for these agents" however Polyheme, as I understand it, is a human blood product and although it does not appear to carry the risks of traditional allogeneic blood products I would imagine that those opposing blood on religous grounds would have the same opposition to Polyheme. Has anyone found this to be true?